Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Kristin Werner, Franziska Lademann, May-Linn Thepkaysone, Beatrix Jahnke, Daniela E. Aust, Christoph Kahlert, Georg Weber, Jürgen Weitz, Robert Grützmann, Christian Pilarsky
Published Dec 26, 2015 · Vol. 7, No. 4 · pp. 3984-3992
Hong Yuen Wong, Grace M. Wang, Sarah Croessmann, Daniel J. Zabransky, David Chu, Joseph P. Garay, Justin Cidado, Rory L. Cochran, Julia A. Beaver, Anita Aggarwal, Min-Ling Liu, Pedram Argani, Alan Meeker, Paula J. Hurley, Josh Lauring, Ben Ho Park
Published Dec 23, 2015 · Vol. 6, No. 42 · pp. 44927-44940
Christopher J. Hanley, Fergus Noble, Matthew Ward, Marc Bullock, Cole Drifka, Massimiliano Mellone, Antigoni Manousopoulou, Harvey E. Johnston, Annette Hayden, Steve Thirdborough, Yuming Liu, David M. Smith, Toby Mellows, W. John Kao, Spiros D. Garbis, Alex Mirnezami, Tim J. Underwood, Kevin W. Eliceiri, Gareth J. Thomas
Published Dec 23, 2015 · Vol. 7, No. 5 · pp. 6159-6174